IRIS

MORISCO, FILOMENA

MORISCO, FILOMENA  

DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 362 (tempo di esecuzione: 0.02 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection 1.1 Articolo in rivista 2001 Andriulli, A; Festa, V; Leandro, G; Rizzetto, M; Aigo, Members; Morisco, Filomena
Spread of hepatitis C virus infection within families 1.1 Articolo in rivista 1998 Caporaso, Nicola; Ascione, A; Stroffolini, T; INVESTIGATORS OF AN ITALIAN MULTICENTER, Group; Morisco, Filomena
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. 1.1 Articolo in rivista 2002 Mazziotti, G; Sorvillo, F; Morisco, Filomena; Carbone, A; Rotondi, M; Stornaiuolo, G; Precone, D; Cioffi, M; Gaeta, Gb; Caporaso, Nicola; Carella, C.
Alfa-glutathione transferases in HCV-related chronic hepatitis: a new predictive index of response to inteferon therapy? 1.1 Articolo in rivista 1998 Loguercio, C; Caporaso, Nicola; Tuccillo, C; Morisco, Filomena; DEL VECCHIO BLANCO, G; DEL VECCHIO BLANCO, C.
Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study. (A report from the HCV study group of the Italian Association for the Study of the Liver) 1.1 Articolo in rivista 1991 Chiaramonte, M; Stroffolini, T; Caporaso, Nicola; Coppola, R; Craxì, A; Gaeta, Gb; Sagnelli, E; Zanetti, A; Morisco, Filomena
IFN impact on liver disease progression in HBeAg negative chronic hepatitis B: a long term italian multicenter AISF study. 4.1 Articoli in Atti di convegno 2005 F., Oliveri; M., Puoti; T., Santantonio; P., Lampertico; G., Colloredo; G., Niro; G., Fattovich; Morisco, Filomena; A., Smedile; Mr, Brunetto
terapia immunosoppressiva e riattivazione del virus B 8.02 Comunicazioni a Convegni o Seminari 2010 Morisco, Filomena
comorbidità da farmaci e tossici 8.02 Comunicazioni a Convegni o Seminari 2010 Morisco, Filomena
le epatiti croniche 8.02 Comunicazioni a Convegni o Seminari 2010 Morisco, Filomena
nutritional and economical value of sorghum-based foods in the gluten free diet 8.02 Comunicazioni a Convegni o Seminari 2010 Morisco, Filomena
CIRANAD 8.05 Partecip. Consigli Scientifici/Direttivi 2008 Morisco, Filomena
risk factors of aminotransferase elevation in a population of virus-free blood donors. A multicentre italian study 4.1 Articoli in Atti di convegno 2008 Morisco, Filomena; A., Mele; G., Taliani; A., Smedile; S., Caronna; G., Niro; M., Levrero; Fiorillo, M. T.; Tosti, M. E.; T., Stroffolini; Caporaso, Nicola
Familial environment and HCV infection. - Author’s reply (Letters to the Editor). 1.1 Articolo in rivista 1995 Caporaso, Nicola; Morisco, Filomena; Ascione, A; Costanzo, G. G.
Thyroid autoimmunity during and after recombinant interferon (rIFN) therapy. 3rd European Congress of Endocrinology 1.5 Abstract in rivista 1994 C., Carella; G., Amato; Biondi, Bernadette; M., Rotondi; A. M., Sinisi; Morisco, Filomena; C., Tuccillo; Caporaso, Nicola; G., Lombardi
Proton Transfer Reaction Time of Flight Mass Spectometry (PTR-ToF-MS) for in vivo breath analysis of rats under different diet conditions 4.1 Articoli in Atti di convegno 2011 E., Aprea; F., Biasioli; L., Cappellin; C., Soukoulis; F., Gasperi; Morisco, Filomena; G., D'Argenio; V., Lembo; V., Fogliano; Caporaso, Nicola
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 1.1 Articolo in rivista 2012 Juran, Bd; Hirschfield, Gm; Invernizzi, P; Atkinson, Ej; Li, Y; Xie, G; Kosoy, R; Ransom, M; Sun, Y; Bianchi, I; Schlicht, Em; Lleo, A; Coltescu, C; Bernuzzi, F; Podda, M; Lammert, C; Shigeta, R; Chan, Ll; Balschun, T; Marconi, M; Cusi, D; Heathcote, Ej; Mason, Al; Myers, Rp; Milkiewicz, P; Odin, Ja; Luketic, Va; Bacon, Br; Bodenheimer HC, Jr; Liakina, V; Vincent, C; Levy, C; Franke, A; Gregersen, Pk; Bossa, F; Gershwin, Me; Deandrade, M; Amos, Ci; Lazaridis, Kn; Seldin, Mf; Siminovitch, Ka; Morisco, Filomena; Italian PBC Genetics Study, Group
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 1.1 Articolo in rivista 2014 Gentile, Ivan; Buonomo, ANTONIO RICCARDO; E., Zappulo; G., Minei; Morisco, Filomena; F., Borrelli; N., Coppola; Borgia, Guglielmo
Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. 1.1 Articolo in rivista 2001 Carella, C; Mazziotti, G; Morisco, Filomena; Manganella, G; Rotondi, M; Tuccillo, C; Sorvillo, F; Caporaso, Nicola; Amato, G.
The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. 1.1 Articolo in rivista 2002 Carella, C; Mazziotti, G; Morisco, Filomena; Rotondi, M; Cioffi, M; Tuccillo, C; Sorvillo, F; Caporaso, Nicola; Amato, G.
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres. 1.1 Articolo in rivista 2013 Cazzagon, N; Trevisani, F; Maddalo, G; Giacomin, A; Vanin, V; Pozzan, C; Del Poggio, P; Rapaccini, G; Di Nolfo, Am; Benvegn?, L; Zoli, M; Borzio, F; Giannini, Eg; Caturelli, E; Chiaramonte, M; Foschi, Fg; Cabibbo, G; Felder, M; Ciccarese, F; Missale, G; Svegliati Baroni, G; Morisco, Filomena; Pecorelli, A; Farinati, F; CA Group, for the I. T. A. L. I.